COMMENTARY

Comparing Medications for Type 2 Diabetes: What's Known

Charles P. Vega, MD

Disclosures

August 30, 2011

In This Article

Conclusion

The management of type 2 diabetes is not monolithic. Physicians need to account for individual patient factors in deciding on a plan of care. Fortunately, we understand more about the nuances of diabetes treatment than in the past, and there are more options to choose from in helping patients to reach their treatment goals. However, there are also substantial gaps in our collective knowledge of the treatment of diabetes, particularly with regard to important patient-related outcomes such as microvascular disease, macrovascular disease, and mortality. Further research should be performed to better inform patients and physicians regarding the best treatment choices for type 2 diabetes.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....